Affordable Access

[Prognosis in limited disease (LD) small cell lung cancer (SCLC) patients according to status performance, local extension of lesions, type of treatment and the completeness of staging].

Authors
  • Remiszewski, Paweł
  • Roszkowski-Sliz, Kazimierz
  • Wiatr, Elzbieta
  • Roszkowska-Sliz, Barbara
  • Zych, Jacek
  • Kurzyna, Marcin
  • Jodkiewicz, Zbigniew
  • Rowińska-Zakrzewska, Ewa
Type
Published Article
Journal
Pneumonologia i alergologia polska
Publication Date
Jan 01, 2003
Volume
71
Issue
3-4
Pages
139–147
Identifiers
PMID: 14587419
Source
Medline
License
Unknown

Abstract

The aim of this study was to assess the prognosis in LD SCLC pts according to their performance status, local extension of lesions, type of treatment and the completeness of staging. In the period 01.01.1986-31.12.1996 in the Institute of Tuberculosis and Chest Diseases 579 consecutive SCLC pts were treated. LD was diagnosed in 345 pts. In 193 out of them the staging was complete that is in addition to chest x-ray, abdomen USG/CT, brain CT/MRI and bilateral bone marrow trepanobiopsy was done. 152 pts were also regarded as limited but the staging was not complete. LD pts proved by complete staging survived significantly longer (median survival 15.7 months) than others (median survival 10.2 months). The pts in whom complete staging was done were however in better performance status and had smaller local extension of lesions and had more often radiotherapy than others. Status performance, local extension of lesions and radiotherapy but also completeness of staging were independent prognostic factors in multivariate analysis.

Report this publication

Statistics

Seen <100 times